共有 50 笔近期内部人交易记录记录,涉及 Evelo Biosciences, Inc. (EVLO), 包括 24 笔买入 和 24 笔卖出. 内部人买入总额为 $3.5M 内部人卖出总额为 $126.54K.
近期活跃的重要内部人包括 Gill Simba, Bodmer Mark, Mchale Duncan. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — EVLO
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2023-11-08 |
Gill Simba |
President & CEO |
知情卖出 |
172 |
$0.33 |
$56.76 |
17,758 |
| 2023-11-08 |
Bodmer Mark |
CSO, President of R&d |
知情卖出 |
3,163 |
$0.33 |
$1.04K |
25,732 |
| 2023-11-08 |
Mchale Duncan |
Chief Medical Officer |
知情卖出 |
3,103 |
$0.33 |
$1.02K |
16,984 |
| 2023-11-08 |
Thorell Marella |
Chief Financial Officer |
知情卖出 |
1,811 |
$0.33 |
$597.63 |
22,259 |
| 2023-11-07 |
Gill Simba |
President & CEO |
期权行权(卖出) |
1,172 |
- |
- |
15,236 |
| 2023-11-07 |
Bodmer Mark |
CSO, President of R&d |
期权行权(卖出) |
6,625 |
- |
- |
6,625 |
| 2023-11-07 |
Mchale Duncan |
Chief Medical Officer |
期权行权(卖出) |
6,500 |
- |
- |
6,500 |
| 2023-11-07 |
Thorell Marella |
Chief Financial Officer |
期权行权(卖出) |
6,500 |
- |
- |
6,500 |
| 2023-11-02 |
Bodmer Mark |
CSO, President of R&d |
知情卖出 |
6,854 |
$0.33 |
$2.26K |
22,270 |
| 2023-11-02 |
Mchale Duncan |
Chief Medical Officer |
知情卖出 |
6,854 |
$0.33 |
$2.26K |
13,587 |
| 2023-11-02 |
Thorell Marella |
Chief Financial Officer |
知情卖出 |
3,999 |
$0.33 |
$1.32K |
17,570 |
| 2023-11-01 |
Bodmer Mark |
CSO, President of R&d |
期权行权(卖出) |
12,500 |
- |
- |
25,000 |
| 2023-11-01 |
Mchale Duncan |
Chief Medical Officer |
期权行权 |
12,500 |
- |
- |
20,441 |
| 2023-11-01 |
Thorell Marella |
Chief Financial Officer |
期权行权 |
12,500 |
- |
- |
21,569 |
| 2023-09-28 |
Gill Simba |
President & CEO |
知情卖出 |
1,996 |
$3.94 |
$7.86K |
16,758 |
| 2023-09-27 |
Gill Simba |
President & CEO |
期权行权 |
15,000 |
- |
- |
18,754 |
| 2023-09-11 |
Bodmer Mark |
CSO, President of R&d |
限制性股票授予 (RSU) |
37,500 |
- |
- |
37,500 |
| 2023-09-11 |
Mchale Duncan |
Chief Medical Officer |
限制性股票授予 (RSU) |
37,500 |
- |
- |
37,500 |
| 2023-09-11 |
Thorell Marella |
Chief Financial Officer |
限制性股票授予 (RSU) |
37,500 |
- |
- |
37,500 |
| 2023-08-08 |
Gill Simba |
President & CEO |
知情卖出 |
342 |
$9.51 |
$3.25K |
3,754 |
| 2023-08-08 |
Bodmer Mark |
CSO, President of R&d |
知情卖出 |
3,128 |
$9.51 |
$29.75K |
16,624 |
| 2023-08-08 |
Mchale Duncan |
Chief Medical Officer |
知情卖出 |
3,434 |
$9.51 |
$32.66K |
7,941 |
| 2023-08-08 |
Thorell Marella |
Chief Financial Officer |
知情卖出 |
2,004 |
$9.51 |
$19.06K |
9,069 |
| 2023-08-07 |
Gill Simba |
President & CEO |
期权行权 |
1,171 |
- |
- |
4,096 |
| 2023-08-07 |
Bodmer Mark |
CSO, President of R&d |
期权行权(卖出) |
6,625 |
- |
- |
13,250 |
| 2023-08-07 |
Mchale Duncan |
Chief Medical Officer |
期权行权 |
6,500 |
- |
- |
11,375 |
| 2023-08-07 |
Thorell Marella |
Chief Financial Officer |
期权行权 |
6,500 |
- |
- |
11,073 |
| 2023-07-11 |
Moore Jeffrey R. |
Director |
未知 |
- |
- |
- |
- |
| 2023-07-11 |
Moore Jeffrey R. |
Director |
限制性股票授予 (RSU) |
2,000 |
$3.38 |
$6.76K |
2,000 |
| 2023-07-11 |
Reynolds Alexander C |
Director |
未知 |
- |
- |
- |
- |
| 2023-07-11 |
Reynolds Alexander C |
Director |
限制性股票授予 (RSU) |
2,000 |
$3.38 |
$6.76K |
2,000 |
| 2023-07-11 |
Flagship Ventures Fund Iv General Partner Llc |
10 Percent Owner |
知情买入 |
1,082,251 |
$2.31 |
$2.5M |
1,461,795 |
| 2023-07-11 |
Horizon Technology Finance Corp |
10 Percent Owner |
处置 |
- |
- |
- |
2,164,502 |
| 2023-06-08 |
Gill Simba |
President & CEO |
限制性股票授予 (RSU) |
1,000,000 |
$0.97 |
$970K |
1,000,000 |
| 2023-06-08 |
Melas Kyriazi Theo |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-06-08 |
Mchugh Julie |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-06-08 |
Rosiello Robert L. |
Director |
限制性股票授予 (RSU) |
30,000 |
$0.11 |
$3.3K |
30,000 |
| 2023-06-08 |
Gutierrez-ramos Jose-carlos |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-06-08 |
Hohneker John |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-06-08 |
Andres Juan |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-06-08 |
Mcinnes Iain B. |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-06-08 |
Williams Tonya |
Director |
限制性股票授予 (RSU) |
20,000 |
$0.11 |
$2.2K |
20,000 |
| 2023-05-23 |
Bodmer Mark |
CSO, President of R&d |
知情卖出 |
22,571 |
$0.14 |
$3.2K |
262,557 |
| 2023-05-08 |
Gill Simba |
President & CEO |
知情卖出 |
3,537 |
$0.13 |
$443.89 |
58,512 |
| 2023-05-08 |
Bodmer Mark |
CSO, President of R&d |
知情卖出 |
68,014 |
$0.13 |
$8.54K |
285,128 |
| 2023-05-08 |
Mchale Duncan |
Chief Medical Officer |
知情卖出 |
66,730 |
$0.13 |
$8.37K |
97,516 |
| 2023-05-08 |
Thorell Marella |
Chief Financial Officer |
知情卖出 |
38,531 |
$0.13 |
$4.84K |
91,469 |
| 2023-05-07 |
Gill Simba |
President & CEO |
期权行权 |
23,437 |
- |
- |
62,049 |
| 2023-05-07 |
Bodmer Mark |
CSO, President of R&d |
期权行权 |
132,500 |
- |
- |
353,142 |
| 2023-05-07 |
Mchale Duncan |
Chief Medical Officer |
期权行权 |
130,000 |
- |
- |
164,246 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期